ISLAMABAD OCT: A new study published in a special edition of Science highlights the connections between particular cell types and various prevalent neuropsychiatric conditions.In the human brain.
<p>A special kind of genetic test that helps determine the best antidepressant for patients with moderate-to-severe depression could generate substantive health system savings and greatly improve patient outcomes, according to new research from the University of British Columbia. The study, published today in <a href="https://www.cmaj.ca/lookup/doi/10.1503/cmaj.221785"><em>CMAJ</em></a>, shows that in B.C. alone, implementing pharmacogenomic testing could save the provincial public health system an estimated $956 million over 20 years.</p>
Kalamazoo company uses DNA swabs to connect patients with mental health meds mlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mlive.com Daily Mail and Mail on Sunday newspapers.
It often takes months of experimentation to find an effective psychotropic drug. Up to half of patients with major depressive disorder do not respond to the first antidepressant prescribed. Kalamazoo s Genemarkers is among those offering a promising
The largest brain cell 'atlas' to date could help improve our understanding of neuropsychiatric conditions, such as schizophrenia, bipolar disorder, Alzheimer’s disease, and major depression.